3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
1
Surgery
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Ductal Adenocarcinoma
1
Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer
1
Multiple Myeloma
1
Medulloblastoma
1
Lung Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
HER2-positive Breast Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Cancer Invasive
1
Interventions
Oxaliplatin
7
Fluorouracil
7
Paclitaxel
5
Leucovorin
5
pembrolizumab
4
Trastuzumab
4
Radiation
4
Capecitabine
4
tislelizumab
3
Taxes
3
Specimen Handling
3
Nivolumab
3
Carboplatin
3
ulixertinib
2
trastuzumab biosimilar HLX02
2
patritumab deruxtecan
2
Surgical Procedures, Operative
2
Radiotherapy
2
Pemetrexed
2
PF-05280014
2
Ontruzant
2
Ogivri
2
Irinotecan
2
Exercise
2
Docetaxel
2
Cisplatin
2
CT-P6
2
zolbetuximab
1
zimberelimab
1
zanidatamab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Neoplasms
×
Neoadjuvant Therapy
×
30 days
×
Clear all
No trials found.